BioSpace News Archive

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

Opthea Limited, a clinical stage biopharmaceutical company developing a novel therapy to treat highly prevalent and progressive retinal diseases, announces the launch of its initial public offering of American Depositary Shares, each of which will represent eight of the Company’s ordinary shares, in the United States.

CStone Pharmaceuticals announced the completion of the Share Subscription Agreement through which an affiliate of Pfizer Inc. subscribed for newly issued CStone shares at approximately US$200 million, bringing into effect the multifaceted strategic collaboration that the companies announced on September 30, 2020.

Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. announces that it received investigational new drug application approval from FDA for its drug candidate ASC42, to conduct clinical trials for non-alcoholic steatohepatitis indication.

InnoCare Pharma, a clinical stage biopharmaceutical company, announced that the Company has appointed Dr. Manish Tandon as Vice President of Business Development, reporting to the Co-founder, Chairman and CEO, Dr. Jasmine Cui.